228 related articles for article (PubMed ID: 22238690)
1. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver.
Moya M; Benet M; Guzmán C; Tolosa L; García-Monzón C; Pareja E; Castell JV; Jover R
PLoS One; 2012; 7(1):e30014. PubMed ID: 22238690
[TBL] [Abstract][Full Text] [Related]
2. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.
Guzmán C; Benet M; Pisonero-Vaquero S; Moya M; García-Mediavilla MV; Martínez-Chantar ML; González-Gallego J; Castell JV; Sánchez-Campos S; Jover R
Biochim Biophys Acta; 2013 Apr; 1831(4):803-18. PubMed ID: 23318274
[TBL] [Abstract][Full Text] [Related]
3. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage.
Hughes DE; Stolz DB; Yu S; Tan Y; Reddy JK; Watkins SC; Diehl AM; Costa RH
Hepatology; 2003 Jun; 37(6):1414-24. PubMed ID: 12774021
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis.
García-Monzón C; Petrov PD; Rey E; Marañón P; Del Pozo-Maroto E; Guzmán C; Rodríguez de Cía J; Casado-Collado AJ; Vargas-Castrillón J; Saez A; Miquilena-Colina ME; Lo Iacono O; Castell JV; González-Rodríguez Á; Jover R
Am J Pathol; 2018 Dec; 188(12):2800-2810. PubMed ID: 30248338
[TBL] [Abstract][Full Text] [Related]
7. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
9. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
10. Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver.
Canivet CM; Bonnafous S; Rousseau D; Leclere PS; Lacas-Gervais S; Patouraux S; Sans A; Luci C; Bailly-Maitre B; Iannelli A; Tran A; Anty R; Gual P
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165705. PubMed ID: 32001301
[TBL] [Abstract][Full Text] [Related]
11. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
Hao L; Ito K; Huang KH; Sae-tan S; Lambert JD; Ross AC
Metabolism; 2014 Oct; 63(10):1352-62. PubMed ID: 25060692
[TBL] [Abstract][Full Text] [Related]
12. Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes.
Yalley A; Schill D; Hatta M; Johnson N; Cirillo LA
J Biol Chem; 2016 Apr; 291(16):8848-61. PubMed ID: 26929406
[TBL] [Abstract][Full Text] [Related]
13. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
14. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
[TBL] [Abstract][Full Text] [Related]
15. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
16. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.
Khalifa O; Al-Akl NS; Errafii K; Arredouani A
Sci Rep; 2022 Feb; 12(1):2226. PubMed ID: 35140289
[TBL] [Abstract][Full Text] [Related]
18. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism.
Wang Y; Zhang Y; Qian H; Lu J; Zhang Z; Min X; Lang M; Yang H; Wang N; Zhang P
PLoS One; 2013; 8(8):e72315. PubMed ID: 23951308
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis.
Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H
Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515
[TBL] [Abstract][Full Text] [Related]
20. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
